// Publications


Learn more about eTheRNA, our research and development of products. 

eTheRNA is present at several conferences. Download our posters presented at those conferences below to get more information about us, our research and developments. 

A phase I study (E011-MEL) of a TriMix-based mRNA immunotherapy (ECI-006) in resected melanoma patients: Analysis of safety and immunogenicity

55th Annual Meeting of the American Society of Clinical Oncology (ASCO), 21-23 May 2019

Multiclonal T cell dendritic cell vaccine immune responses correlate with clinical response in TrimixDC-MEL IPI study, a study with Trimix/tumor antigen mRNA dendritic cells plus ipilimumab in patients with advanced melanoma.

17th Annual Meeting of the Association for Cancer Immunotherapy, 21-23 May 2019

Galileilaan 19, 2845 Niel, Belgium

Our Address

Our Mailbox

+32 3 369 17 40

Our Phone

© 2020 Etherna | Studio Hanswijk